[CLYM]

Mid 2026-10-25 08:58:49

Climb Bio reports early data on budoprutug for kidney diseases

Row 2026-10-12 20:54:48

H.C. Wainwright reiterates Climb Bio stock rating ahead of data

Mid 2026-10-05 19:24:49

Raymond James reiterates Strong Buy on Climb Bio stock ahead of data

Row 2026-09-04 01:19:17

Climb Bio slips after early-stage trial data for kidney disease drug